Kevin Guest Net Worth

The estimated Net Worth of Kevin Guest is at least $8.64 Millón dollars as of 11 March 2024. Mr. Guest owns over 11,011 units of Usana Health Sciences Inc stock worth over $391,104 and over the last 19 years he sold USNA stock worth over $4,090,167. In addition, he makes $4,157,830 as Chairman of the Board y Chief Executive Officer at Usana Health Sciences Inc.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Mr. Guest USNA stock SEC Form 4 insiders trading

Kevin has made over 34 trades of the Usana Health Sciences Inc stock since 2012, according to the Form 4 filled with the SEC. Most recently he sold 11,011 units of USNA stock worth $539,539 on 11 March 2024.

The largest trade he's ever made was exercising 29,934 units of Usana Health Sciences Inc stock on 22 August 2017 worth over $862,399. On average, Kevin trades about 6,063 units every 81 days since 2006. As of 11 March 2024 he still owns at least 10,491 units of Usana Health Sciences Inc stock.

You can see the complete history of Mr. Guest stock trades at the bottom of the page.

Kevin Guest biography

Kevin G. Guest has been appointed as Chairman of the Board, Chief Executive Officer of the Company effective 5/1/2020. Mr. Guest joined USANA on a part-time basis in April 2003, as Executive Director of Media and Events. Following our acquisition of the media, video, and event-productions company, FMG Productions founded by Mr. Guest, he became a full-time employee of the Company and he was promoted to Vice President of Media and Events in February 2004. In January 2006, he was appointed Executive Vice President of Marketing and served in that role until July 2008, when he was appointed Chief Marketing Officer. Mr. Guest served in this role until May 2011, when he was appointed President of North America. In October 2012, he was appointed President of the Americas, Europe and South Pacific. In August 2014, Mr. Guest was appointed President of USANA and served in this role until August 2015, when he was appointed Co-Chief Executive Officer. He served in this role until November 2016 when he was appointed Chief Executive Officer. Mr. Guest earned a B.A. in Communications from Brigham Young University. Mr. Guest's important role as the leading force of our management and sales efforts and his talent as a motivating leader qualify him to serve as a member of the Board.

What is the salary of Kevin Guest?

As the Chairman of the Board y Chief Executive Officer of Usana Health Sciences Inc, the total compensation of Kevin Guest at Usana Health Sciences Inc is $4,157,830. There are no executives at Usana Health Sciences Inc getting paid more.

How old is Kevin Guest?

Kevin Guest is 57, he's been the Chairman of the Board y Chief Executive Officer of Usana Health Sciences Inc since 2020. There are 9 older and 14 younger executives at Usana Health Sciences Inc. The oldest executive at Usana Health Sciences Inc is Dr. Myron W. Wentz, 80, who is the Founder & Chairman Emeritus.

What's Kevin Guest's mailing address?

Kevin's mailing address filed with the SEC is 3838 WEST PARKWAY BLVD, , SALT LAKE CITY, UT, 84120.

Insiders trading at Usana Health Sciences Inc

Over the last 28 years, insiders at Usana Health Sciences Inc have traded over $838,318,381 worth of Usana Health Sciences Inc stock and bought 4,600 units worth $120,973 . The most active insiders traders include Myron W Wentz, Global Ltd Gull y Myron W Gull Global Ltd Wentz. On average, Usana Health Sciences Inc executives and independent directors trade stock every 7 days with the average trade being worth of $572,994. The most recent stock trade was executed by Paul A. Jones on 13 August 2024, trading 6,266 units of USNA stock currently worth $240,489.

What does Usana Health Sciences Inc do?

usana health sciences’ mission is to develop and provide the highest quality, science-based health products, distributed internationally through network marketing, creating a rewarding financial opportunity for our independent associates, shareholders, and employees. we’ve got history. not baggage. we’ve been around since 1992, so we’re experienced (we’ve heard that’s a plus). and we look great for our age. plus, we have substance to go along with our great looks. we’ve got top-notch manufacturing facilities, our own scientists and research and development team, and the highest standards for our nutritional products. we have an award-winning compensation plan and award-winning products. we don’t like to brag, but we come pretty highly recommended. that’s because we got off on the right foot. we were founded by a scientist—not a corporate suit. usana’s founder, myron wentz, is an internationally recognized microbiologist, immunologist, and pioneer in infectious disease diagnosis. but su

Complete history of Mr. Guest stock trades at Usana Health Sciences Inc

Usana Health Sciences Inc executives and stock owners

Usana Health Sciences Inc executives and other stock owners filed with the SEC include:

• Kevin Guest,
  Chairman of the Board, Chief Executive Officer
• Jim Brown,
  President
• Kevin G. Guest,
  Chairman & CEO
• G Hekking,
  Chief Financial Officer
• David Mulham,
  Chief Field Development Officer
• Walter Noot,
  Chief Operating Officer
• Jim Brown,
  Pres
• Daniel Macuga,
  Chief Communications and Marketing Officer
• G. Douglas Hekking,
  Chief Financial Officer
• David Mulham,
  Chief Sales Officer
• Walter Noot,
  Chief Operating Officer
• Paul Jones,
  Chief Leadership Development Officer
• Peggie Pelosi,
  Independent Director
• Gilbert Fuller,
  Lead Independent Director
• Robert Anciaux,
  Senior Director
• Frederic Winssinger,
  Independent Director
• Feng Peng,
  Independent Director
• Timothy Wood,
  Independent Director
• Dr. Myron W. Wentz,
  Founder & Chairman Emeritus
• John Fleming,
  Director
• Brent Neidig,
  Chief Officer and Managing Director of China
• P. Joshua Foukas,
  Chief Legal Officer, General Counsel and Corporate Secretary
• Robert Sinnott,
  Chief Scientific Officer
• P. Joshua Foukas,
  Chief Legal Officer, Gen. Counsel & Corp. Sec.
• Patrique Richards,
  Exec. Director of Investor Relations & Bus. Devel.
• Dr. John Cuomo,
  Exec. Director of Product Devel. & Technology
• J Scott Nixon,
  Director
• Myron W Gull Global Ltd Wentz,
  
• Robert Auciaux,
  
• Global Ltd Gull,
  10% owner
• Myron W Wentz,
  CEO
• Deborah Woo,
  E.V.P. of Sales
• Donald R. Williams,
  Director
• Dave Wentz,
  President
• James Bramble,
  
• Jerry G Mcclain,
  Director
• Denis E Waitley,
  Director
• Roy Truett,
  Chief Information Officer
• Doug Braun,
  Chief Marketing Officer
• Ronald S Poelman,
  Director
• Rick Stambaugh,
  Chief Information Officer
• Holdings Ltd Gull,
  10% owner
• Fred W Cooper,
  Vice President of Operations
• Jeffrey Yates,
  Chief Financial Officer
• Mark H Wilson,
  V.P. of Customer Relations
• Bradford Richardson,
  E.V.P. of Asia Pacific
• G Doug Iiekking,
  CHIEF FINANCIAL OFFICER
• Peter Benedict,
  CHIEF INFORMATION OFFICER
• Joshua Foukas,
  CHIEF LEGAL OFFICER
• Xia Ding,
  Director